Stock NSHS NANOSPHERE HEALTH SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials NanoSphere Health Sciences Inc.

Equities

NSHS

CA63010P2098

Pharmaceuticals

Delayed Canadian Securities Exchange
Other stock markets
 12:41:23 04/05/2024 am IST 		5-day change 1st Jan Change
0.025 CAD 0.00% Intraday chart for NanoSphere Health Sciences Inc. 0.00% +150.00%
30/04 NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 17.07 5.001 1.276 2.176 0.1888 0.077
Enterprise Value (EV) 1 16.86 5.117 1.337 2.045 0.1338 0.0677
P/E ratio -3.61 x -1.43 x -2.16 x -4.05 x -0.67 x -0.34 x
Yield - - - - - -
Capitalization / Revenue 451 x 22.9 x - - - -
EV / Revenue 445 x 23.5 x - - - -
EV / EBITDA -5.67 x -2.88 x -2.52 x -5.99 x - -
EV / FCF -11 x -37.3 x 6.95 x -4.81 x 21.3 x 1.05 x
FCF Yield -9.07% -2.68% 14.4% -20.8% 4.7% 95%
Price to Book 20.4 x -5.44 x -0.88 x -2.02 x -0.14 x -0.05 x
Nbr of stocks (in thousands) 5,068 5,418 5,418 10,275 10,275 10,275
Reference price 2 3.368 0.9232 0.2355 0.2118 0.0184 0.007496
Announcement Date 30/04/19 15/06/20 30/04/21 25/04/22 28/04/23 30/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0379 0.218 - - - -
EBITDA 1 -2.972 -1.779 -0.5298 -0.3413 - -
EBIT 1 -3.017 -1.833 -0.5435 -0.355 -0.2628 -0.2201
Operating Margin -7,964.18% -840.83% - - - -
Earnings before Tax (EBT) 1 -4.515 -3.469 -0.5912 -0.3563 -0.2818 -0.2281
Net income 1 -4.515 -3.469 -0.5912 -0.3563 -0.2818 -0.2281
Net margin -11,918.13% -1,590.92% - - - -
EPS 2 -0.9331 -0.6460 -0.1091 -0.0523 -0.0274 -0.0222
Free Cash Flow 1 -1.529 -0.1371 0.1923 -0.4252 0.006286 0.0643
FCF margin -4,035.33% -62.89% - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/04/19 15/06/20 30/04/21 25/04/22 28/04/23 30/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.12 0.06 - - -
Net Cash position 1 0.21 - - 0.13 0.06 0.01
Leverage (Debt/EBITDA) - -0.0652 x -0.1147 x - - -
Free Cash Flow 1 -1.53 -0.14 0.19 -0.43 0.01 0.06
ROE (net income / shareholders' equity) -200% 8,505% 49.8% 28.2% 23.6% 15.9%
ROA (Net income/ Total Assets) -73% -139% -175% -236% -171% -353%
Assets 1 6.187 2.502 0.3384 0.1507 0.1652 0.0647
Book Value Per Share 2 0.1600 -0.1700 -0.2700 -0.1000 -0.1300 -0.1500
Cash Flow per Share 2 0.0400 0.0100 0 0.0100 0.0100 0
Capex 1 0.3 0.05 - - - -
Capex / Sales 797.68% 24.31% - - - -
Announcement Date 30/04/19 15/06/20 30/04/21 25/04/22 28/04/23 30/04/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
NANOSPHERE HEALTH SCIENCES INC. Stock NanoSphere Health Sciences Inc.
+150.00% 2L
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.28% 4.44TCr
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.60% 2.3TCr
SANDOZ GROUP AG Stock Sandoz Group AG
+19.22% 1.51TCr
CIPLA LIMITED Stock Cipla Limited
+12.87% 1.31TCr
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.67% 1.19TCr
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.33% 698.92Cr
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 678.76Cr
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.22% 551.54Cr
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NSHS Stock
  4. Financials NanoSphere Health Sciences Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW